Excess body weight is a major risk factor for type 2 diabetes (T2D) and associated metabolic
complications, and weight loss has been shown to improve glycemic control and decrease …

We have previously reported that administration of low molecular weight chitosan
oligosaccharide (GO2KA1) significantly suppressed postprandial blood glucose rise with …

Background Type 2 diabetes is a serious problem for developed countries. Prevention of
prediabetes progression to type 2 diabetes with the use of natural products appears to a cost …

We aimed to evaluate the effect of chitosan oligosaccharide (GO2KA1) supplementation on
glucose control in subjects with prediabetes. This study was a randomized, double-blind …

The 3T3-L1 cell line is a well-established and commonly used in vitro model to assess
adipocyte differentiation. Over the course of several days, confluent 3T3-L1 cells can be …

This research investigated the effect of enzymatically digested low molecular weight (MW)
chitosan oligosaccharide on type 2 diabetes prevention. Three different chitosan …

Galacto-oligosaccharides (GOS) are commonly used as prebiotic with a variety of known
metabolic benefits; however, whether GOS plays a protective role in obesity remains …

In the present study, we performed a differential proteomic analysis using 2‐DE combined
with MS to clarify the molecular mechanism for the suppressive effect of chitosan …

Inhibition of adipogenesis and lipid accumulation has a very crucial role to prevent obesity.
Low molecular weight (LMW) chitosan is known to inhibit fat accumulation and …

AIMS: Fucoidan, consisting of l-fucose together with xylose, galactose and mannose, is a
sulfated polysaccharide from brown seaweeds, which has been reported to affect the …